Key Takeaways
- Margin recovery from pricing, not volume: Gross margin expanded as price corrections taken in Feb–Mar 2022 finally stuck after a six-month gestation, while fixed costs normalized to pre-COVID levels.
- Europe is the deliberate drag on consolidated profits: The gap between standalone and consolidated profitability reflects a planned investment in European expansion, with losses running "well below" the originally planned €20 mn.
- Cash flow strained by inventory bet: Inventory rose ~₹150 Crores as the company built buffer stock to guarantee product availability, a competitive advantage that came at the cost of cash. Management expects a two-to-three-month transition before inventory levels ease.
- Motor plant delayed again: The original vendor for the critical motor production machine was cancelled for non-performance; a new vendor has been selected with delivery now expected by Q4 FY23, pushing full capacity to next year.
- What to watch next quarter: Whether inquiry-to-order conversion velocity holds across sectors, whether the promised inventory unwind actually begins, and whether Q3 sustains beyond the first two months that management already sees as "okay."
Margin Walk: Pricing Gains, Fixed-Cost Normalization
- Price corrections finally landed: Price increases pushed through in February–March 2022 across all products and geographies started gaining traction in Q2, after a long gestation as different markets absorbed them and old inventory cleared. The prior year's problem was runaway weekly cost increases that pricing could not catch up with.
- Fixed costs returned to normal: Employee and other fixed costs rose because the artificially subdued COVID-era levels normalized; management described this as a general increase across all areas with no specific country or event driving it, and expects costs to stay at these levels going forward.
- Currency was a wash: The favorable dollar movement was largely offset by an unfavorable euro, given the company's significant presence in both currency zones, yielding a net benefit of only 1%.
- Pricing ladder moved up vs competitors: Management believes it executed far more aggressive price corrections than competitors, who were slowed by supply chain challenges and long lead times. The company estimates it moved one or two rungs up the pricing ladder, though it is "definitely not higher than Atlas Copco or Ingersoll Rand."
- Cost-to-price ratio at equilibrium: At current pricing levels, the cost-to-price ratio is synchronized; management sees operating profit margin as probably at its peak and says any further meaningful margin expansion must come from topline growth through global expansion.
Jairam Varadaraj: "We are not going to give away prices which are based on cost increases, but if there are cost increases that we have overestimated and to that extent, we need to correct prices, we will do so. So the idea is growth and that too profitably."
Europe: The Deliberate Investment That Weighs on Consolidated Profits
- Planned losses, better than planned: Europe is losing money as part of a deliberate expansion strategy. The original plan was to invest €20 mn as mid-through losses (about ₹160 Crores), but current performance is "well below that" and "better than planned." Management declined to disclose specific half-year or full-year loss figures.
- Breakeven pushed to FY2025: The European operations were originally expected to break even in FY2024, but COVID caused a one-year delay, pushing the target to FY2025.
- Hiring largely complete: The bulk of hiring for sales, marketing, and administration in Europe has been done. Any additional headcount increase will be purely revenue-generating, with no further overhead hiring unless justified by associated revenue.
- Growth from a small base: Europe continues to grow well despite the Ukraine war and energy price problems, progressing per the strategic plan from a very small base in a large market.
Geographic Performance: U.S. Leads, India Holds Without Oxygen Boost
- North America very strong: The U.S. operations team managed supply chain challenges well, making products available with lead times that are competitive and even better than pre-COVID levels.
- India grew despite a tough comp: India grew compared to last year even without the oxygen compressor orders that boosted the prior-year first two quarters. The automotive equipment business also grew over last year's recovery quarter.
- Australia and Southeast Asia recovering: Both regions performed better than last year but remain below expectations, with Southeast Asia's recovery lagging Australia's. Both were particularly affected by COVID.
- Brazil and Middle East doing well: Both regions delivered good performance.
- Standalone vs consolidated gap: The profitability gap between standalone and consolidated numbers is driven by Europe's deliberate losses; management declined to break out specifics for each subsidiary, calling it "too competitive information to share."
Inventory & Cash Flow: The Cost of Availability
- Inventory built as a competitive weapon: Inventory increased ~₹150 Crores because the company planned stock based on worst-case shipping and supply lead times to ensure product availability. This competitive advantage came at the cost of cash flow.
- Unwind expected in two to three months: Management is progressively handling the inventory buildup across all regions and manufacturing. It expects a two-to-three-month transition before results show at the inventory level, though cash flow should start improving before that.
- Receivables flat despite growth: Receivables remained flat even as sales grew, a positive signal on collections.
- Debt reduction promised, not quantified: Management expressed confidence that net closing debt will come down significantly from the current ~₹155 Crores, but declined to predict the exact number at Q3 end or FY end.
- India cash management: The India business is generating cash and using packing credit at very low interest rates, placing funds into deposits for a margin arbitrage.
Demand Outlook: Broad Inquiries, Uncertain Conversion
- Inquiries cut across all industries: Positive growth was seen across all industry verticals except textiles. Inquiry levels are broad-based; the open question is whether they will all convert into finalized orders and at what velocity.
- Textiles may be turning: Textiles has faced challenges for almost a year due to cotton prices, but cotton prices have now dropped and mills are back in the market buying cotton, suggesting a potential pickup. Textiles was never a disproportionately large market for the company.
- Project inquiries are tentative: Flue gas desulfurization has a lot of inquiries; steel mills are talking but saying "let us wait and see"; cement started and is now also saying "let us wait and see."
- Railways a new opportunity: Railways are investing and increasingly looking at private manufacturers for high-capacity, high-horsepower locomotives. The company will participate, but it is a new landscape and difficult to predict linear growth.
- Q3 visibility limited: Management is confident about the first two months of Q3 (November), with topline continuing down the same path as Q2, but is unsure beyond that. Caution stems from the rapid, drastic commodity price changes seen in December 2020.
Jairam Varadaraj: "We have got to keep in mind what happened with commodity prices in a very short period in the month of December in 2020. So the world has demonstrated that things can change quite rapidly, quite drastically, so we are keeping our fingers cross, so we still think that Q3 will be good, but we have to wait and see, so there is a bit of a caution on that."
Motor Plant & Capex: Delayed Again, Vendor Replaced
- Original vendor cancelled: The order with the original vendor for the critical motor production machine was cancelled due to delays and failure to meet specifications. The bank guarantee for the advance payment was invoked. A new vendor has been selected.
- Timeline pushed to Q4: Delivery of the critical machine from the new vendor is expected by the fourth quarter of this financial year. Full capacity for the plant will be available next year.
- Motor volumes still low: Current motor production volumes remain quite low because the machinery was not received; profitability is not yet benefiting from backward integration.
- Larger campus shift being planned: The company is working on a major capex plan to shift city operations to the main campus outside the city; detailing has been ongoing.
- ELGi Sauer capex separate: ELGi Sauer is undertaking capex of around ₹50 Crores, but this is being done by the subsidiary on its own balance sheet, not by the parent.
Strategy & Positioning: Profitable Growth Over Margin Extraction
- Growth prioritized over margin targets: Management would actively discourage staying at the same topline level to achieve the 16% margin target, calling it "milking" the market. The priority is profitable growth, with margin improvement coming from topline expansion through global reach.
- Pricing review underway: The company is still analyzing whether to make price corrections now that raw material costs have come down. The goal is to learn from the past, take a detailed analytical view of the future, and avoid being left behind by volatile raw material changes again.
- Aftermarket a strategic priority: Aftermarket is a strategic focus in all markets, though management cannot predict where it will be in two to three years.
- No European manufacturing exodus seen: Management does not see a big exodus of European companies setting up operations in India. All countries are behaving in a protective manner, looking at in-sourcing manufacturing rather than relocating.
- China Plus One relevant for sourcing companies: The strategy benefits sourcing companies and other brands, but ELGi is not a sourcing company. Management called China Plus One "good rhetoric and emotion at a certain political level" but "rational behavior" at the economic level.
Jairam Varadaraj: "Can we remain the same level of topline and achieve 16% that is a no and I would actively discourage that, because then you are just dropping up, you are extracting margins from the market, you are just milking it, you are not growing it."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Fixed costs | Normalized levels sustained going forward | Ongoing |
| Inventory unwind | Progressive reduction across all regions; cash flow improvement before inventory-level results visible | Two-to-three-month transition |
| Debt reduction | Net closing debt to come down significantly from ~₹155 Crores | No specific quarter or FY-end number given |
| Motor plant critical machine | Delivery from new vendor | Q4 FY23 |
| Motor plant full capacity | Full capacity available | Next year (FY24) |
| European breakeven | Operations reach breakeven | FY2025 (delayed one year from original FY2024 plan by COVID) |
| European hiring | No further overhead hiring unless justified by associated revenue | Ongoing |
| Margin target | 16% operating margin | By FY2025–2026; currently ~14.5% |
| Pricing review | Analytical review of costs and future outlook before deciding on price changes | Underway, no deadline given |
Key Metrics
| Metric | Q2 FY23 |
|---|---|
| Consolidated revenue | ₹738 cr, +12% YoY reported; +18% YoY excluding oxygen concentrators |
| Standalone revenue | ₹448 cr |
| Standalone PBT | ₹95 cr |
| Consolidated PBT | ₹104 cr |
| Operating profit margin | 15.2% |
| EBITDA | ~₹110 cr; management estimate of what it should have been was ~₹160 cr, a ~₹50 cr shortfall due to fixed costs normalizing |
| Volume growth (consolidated) | ~8% |
| Volume growth (India, ex-oxygen) | ~8%; ~2–3% including oxygen |
| Net closing debt | ~₹155 cr, up ₹65 cr from ~₹90 cr in March 2022 |
| Inventory increase | ~₹150 cr during H1 FY23 |
| Capex spent in H1 FY23 | ~₹25 cr; full-year expectation ₹50–55 cr |
| Aftermarket revenue share | 22–23% of global consolidated revenue |
| Domestic revenue share | 40–42% of consolidated revenue; last year was ~55% |
| Currency impact on revenue | ~1% net favorable; dollar gains offset by euro |
| Europe investment plan | Losses well below the originally planned €20 mn (~₹160 cr) mid-through losses; breakeven now targeted FY2025 |